In vitro and in vivo studies reveal that Kindlin-2 loss dramatically reduces insulin expression and secretion and impairs β-cell proliferation and mass, resulting in severe diabetes-like phenotypes. The gene discussed is FERMT2; the disease is diabetes mellitus.